Pharmaceutical composition comprising anxiolytic drugs and beta-

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424330, A61K 3133, A61K 31135

Patent

active

041906543

ABSTRACT:
A pharmaceutical composition for the therapeutical treatment of anxiety and neurodystonic states characterized by combining an anxiolytic belonging to the class of the benzodiazepines and a beta-adrenergic receptor blocking agent, in which said benzodiazepinic anxiolytic is 3-N,N-dimethylcarbamoyloxy-1-methyl, 5-phenyl, 7-chloro, 1,3-dihydro-2H-1,4-benzodiazepin-2-one- and said beta-adrenergic receptor blocking agent is 1-(0-methoxyphenoxy)-3-isopropylamino-propan-2-olo.

REFERENCES:
patent: 3867529 (1975-02-01), Ferrari et al.
Chem. Abst., vol. 71, 30165r, (1969).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition comprising anxiolytic drugs and beta- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising anxiolytic drugs and beta-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising anxiolytic drugs and beta- will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2113393

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.